Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Joel Tarning
Parasitological efficacy of sulfadoxine-pyrimethamine and amodiaquine for seasonal malaria chemoprevention in Africa
Abstract Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) protects millions of African children, yet the contribution of each drug to preventive efficacy remains unclear. We pooled individual-level data on drug concentrations and malaria infection in 934 children from Uganda (NCT05323721), Mozambique (NCT05186363), and Burkina Faso (NCT05478954).
A dynamic pharmacometric framework defining the relationship between ivermectin exposure and mosquito lethality
Abstract Ivermectin is used in the treatment of several neglected tropical diseases. Studies have shown that it effectively kills anopheline mosquitoes. However, the relationship between the pharmacokinetic properties and mosquito-lethal effects have not been described quantitatively. Pharmacokinetic properties and mosquito-lethal effects associated with a single oral administration of ivermectin were evaluated in two healthy volunteer trials in Thailand.
Safety, tolerability and pharmacokinetic properties of intranasal artesunate in a first in human phase 1 trial
Abstract Malaria is responsible for more than half a million deaths each year. Parenteral artesunate is the recommended first-line treatment for severe malaria, but prompt treatment is often delayed affecting patient outcomes. Rectal artesunate is recommended as a pre-referral treatment but shows variable absorption and can be problematic when treating children with gastrointestinal disturbances.
Physiologically-Based Pharmacokinetic Modeling to Investigate Piperaquine Exposure in Pregnant Women Using an Individualized Profile Approach
Malaria in pregnancy poses significant risks to the mother, fetus, and neonate, necessitating effective treatment and prevention strategies. This study explored the application of an individualized ('virtual twin') physiologically-based pharmacokinetic (PBPK) modeling approach to the antimalarial drug piperaquine in pregnant women. The piperaquine PBPK model was previously developed and validated within Simcyp for a healthy non-pregnant population.
Assessing transporter‐mediated rifampin-linezolid interaction using physiologically‐based pharmacokinetic modelling
|
What is already known about this subject? Rifampin has been shown to significantly reduce the plasma exposure of linezolid in clinical studies, but the primary transporter mediating this interaction remains controversial. High dose rifampin (>20 mg/kg) plus linezolid have shown potential in the treatment of tuberculous meningitis, but the extent of their drug-drug interaction must be evaluated to ensure both safety and efficacy.
By Hoang Nguyen Verified, Hoàng Nguyên, Hoàng Nguyễn Verified, vinh pham, Richard M. Hoglund, Joel Tarning
|
British Pharmacological Society
Dose‐Optimization of a Novel Co‐Formulated Triple Combination Antimalarial Therapy: Artemether‐Lumefantrine‐Amodiaquine
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Artemisinin-based combination therapy (ACT) is the first-line therapy for uncomplicated P. falciparum malaria. Artemisinin-resistant P. falciparum was first identified in Southeast Asia, but artemisinin resistance has recently emerged in East Africa. Triple-ACTs have emerged as a viable alternative treatment to combat declining ACT efficacy due to multi-drug-resistant malaria. WHAT QUESTION DID THIS STUDY ADDRESS?
Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
1 INTRODUCTION Sub-Saharan Africa bears more than 93% of morbidity and mortality due to Plasmodium falciparum malaria. In this setting, approximately 36% of the burden is experienced in infants.1, 2 After birth, an infant (a child <1 year of age) is protected from malaria due to the immunity conferred by the mother.
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants - Nature Communications
Abstract Current guidelines advise against primaquine treatment for breastfeeding mothers to avoid the potential for haemolysis in infants with G6PD deficiency. To predict the haemolytic risk, the amount of drug received from the breast milk and the resulting infant drug exposure need to be characterised. Here, we develop a pharmacokinetic model to describe the drug concentrations in breastfeeding women using venous, capillary, and breast milk data.
Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Adherence to medication is critical to the outcome of the treatment. To date, many approaches have been proposed for adherence assessment, such as patient self-reports, pill counts, etc. However, pharmacology-based approaches, with the measurement of drug concentrations, are considered to be the most objective approach for adherence assessment of recent dose events. WHAT QUESTION DID THIS STUDY ADDRESS?
Identification of trans-genus biomarkers for early diagnosis of intestinal schistosomiasis and progression of gut pathology in a mouse model using metabolomics
Loading metrics Open Access Peer-reviewed Research Article Citation: Chienwichai P, Tipthara P, Tarning J, Limpanont Y, Chusongsang P, Chusongsang Y, et al. (2024) Identification of trans-genus biomarkers for early diagnosis of intestinal schistosomiasis and progression of gut pathology in a mouse model using metabolomics. PLoS Negl Trop Dis 18(2): e0011966.
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Introduction Most antimalarial drugs have required dose optimisation following their initial introduction. It appears likely that tafenoquine is not an exception. The optimal doses of the 8-aminoquinoline drugs (primaquine and tafenoquine) in the prevention of Plasmodium vivax relapse are a trade-off between the blood stage and hypnozoite effects (benefiting all patients), and the haemolytic risk in the sub-group of patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance - Nature Communications
Abstract Approximately 10% of antimicrobials used by humans in low- and middle-income countries are estimated to be substandard or falsified. In addition to their negative impact on morbidity and mortality, they may also be important drivers of antimicrobial resistance. Despite such concerns, our understanding of this relationship remains rudimentary.
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening - Nature Communications
Abstract Malaria parasites like Plasmodium falciparum multiply in red blood cells (RBC), which are cleared from the bloodstream by the spleen when their deformability is altered. Drug-induced stiffening of Plasmodium falciparum-infected RBC should therefore induce their elimination from the bloodstream. Here, based on this original mechanical approach, we identify safe drugs with strong potential to block the malaria transmission.
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
Decision letter after peer review: Thank you for submitting your article "The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Dominique Soldati-Favre as the Senior Editor.
Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients
Clinical Therapeutics Sophie G. Zaloumis, Jason M. Whyte, Joel Tarning, Sanjeev Krishna, James M. McCaw, Pengxing Cao, Michael T. White, Saber Dini, Freya J. I. Fowkes, Richard J. Maude, Peter Kremsner, Arjen Dondorp, Ric N. Price, Nicholas J. White, Julie A. Simpson DOI: 10.1128/AAC.02346-20 ABSTRACT Most deaths from severe falciparum malaria occur within 24 h of presentation to a hospital.
Concentration-dependent mortality of chloroquine in overdose
Abstract Hydroxychloroquine and chloroquine are used extensively in malaria and rheumatological conditions, and now in COVID-19 prevention and treatment. Although generally safe they are potentially lethal in overdose. In-vitro data suggest that high concentrations and thus high doses are needed for COVID-19 infections, but as yet there is no convincing evidence of clinical efficacy.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joel
Contact Joel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack